Probenecid Improves Cardiac Function in Patients With Heart Failure With Reduced Ejection Fraction In Vivo and Cardiomyocyte Calcium Sensitivity In Vitro

BACKGROUND: Transient receptor potential vanilloid 2 is a calcium channel activated by probenecid. Probenecid is a Food and Drug Administration–approved uricosuric drug that has recently been shown to induce positive lusitropic and inotropic effects in animal models through cardiomyocyte transient r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Principais autores: Robbins, Nathan, Gilbert, Mark, Kumar, Mohit, McNamara, James W., Daly, Patrick, Koch, Sheryl E., Conway, Ginger, Effat, Mohamed, Woo, Jessica G., Sadayappan, Sakthivel, Rubinstein, Jack
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850150/
https://ncbi.nlm.nih.gov/pubmed/29331959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.007148
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados